Lung infections caused by viruses, such as flu and RSV, are common. But in some cases they can lead to severe illness that can require hospitalisation and intensive care admission. We are following the science to understand what causes these severe responses and identify new targets to help treat them. One of our key targets is IL-33, a key driver of inflammation that can be activated in response to infections. Find out more about viral lung infections and the progression to acute respiratory distress syndrome (ARDS) in this animation.

Follow the science further on our website: https://www.astrazeneca.com/what-scie...

------------------------------------------------------------
Global site: https://www.astrazeneca.com/
Careers site: https://careers.astrazeneca.com/

Follow us:
Twitter:   / astrazeneca  
LinkedIn:   / astrazeneca  
Instagram:   / astrazeneca  
Facebook:   / astrazeneca